- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
An investigator initiated phase II clinical trial of tamibarotene (AM80G) for chronic graft-versus-host disease
-
- Nishimori Hisakazu
- Department of Hematology and Oncology, Okayama University Hospital
-
- Maeda Yoshinobu
- Department of Hematology and Oncology, Okayama University Hospital
Bibliographic Information
- Other Title
-
- 慢性移植片対宿主病に対するタミバロテン（AM80G）の医師主導臨床第Ⅱ相試験
- マンセイ イショクヘン タイ シュクシュビョウ ニ タイスル タミバロテン(AM80G)ノ イシ シュドウ リンショウ ダイ Ⅱ ソウ シケン
Search this article
Journal
-
- Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
-
Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 127 (2), 133-137, 2015
Okayama Medical Association
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679851531136
-
- NII Article ID
- 130005096255
-
- NII Book ID
- AN00032489
-
- ISSN
- 18824528
- 00301558
-
- NDL BIB ID
- 026690218
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- IRDB
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE